XML 58 R41.htm IDEA: XBRL DOCUMENT v3.25.4
FAIR VALUE MEASUREMENTS (Tables)
 12 Months Ended
Dec. 31, 2025
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets Measured on Recurring Basis
As of December 31, 2025 and December 31, 2024, the assets and liabilities measured at fair value on a recurring basis were as set forth in the table below:
 
 
 
(In millions)		December 31, 2025Quoted Prices in Active Markets for Identical Assets (Level 1)Significant Other Observable Inputs (Level 2)Significant Unobservable Inputs (Level 3)
Assets:
Cash equivalents$10.2 $10.2 $— $— 
Marketable securities$9.7 $9.7 $— $— 
Total assets$19.9 $19.9 $— $— 
Liabilities:
Total liabilities$— $— $— $— 
December 31, 2024Quoted Prices in Active Markets for Identical Assets (Level 1)Significant Other Observable Inputs (Level 2)Significant Unobservable Inputs (Level 3)
Assets:
Cash equivalents$5.0 $5.0 $— $— 
Total assets$5.0 $5.0 $— $— 
Liabilities:
Share swap transaction$2.5 $2.5 $— $— 
Contingent payments related to acquisition$5.0 — — $5.0 
Total liabilities$7.5 $2.5 $— $5.0 
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation The following table provides a roll-forward of the contingent consideration liability, which is included in "Accrued expenses and other liabilities" as of December 31, 2025 and "Other long-term liabilities" as of December 31, 2024 in the consolidated balance sheets:
(In millions)20252024
Fair value at beginning of period$5.0 $3.0 
Additions— — 
Adjustment to prior year acquisition— 1.3 
Change in fair value recognized in earnings— 0.7 
Payments(5.0)— 
Fair value at end of period$— 5.0